 |
市场调查报告书
商品编码
1198707
子宫操纵器设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)Uterine Manipulation Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
子宫操纵器设备市场预计在 2022-2027 年研究期间的复合年增长率为 5.8%。
由于 SARS-CoV-2 的高传播性，COVID-19 大流行转移了资源来照顾 COVID-19 患者，影响了非 COVID-19 医疗保健服务，并已成为全球医疗保健的挑战中国的供应商，也正在影响子宫操纵器设备市场。 例如，根据 2021 年 10 月发表的一项研究“分析大型学术医院系统的 COVID-19 反应和对妇科手术的影响”，许多患者在大流行期间转向妇科手术。2020 年进行了 942 次妇科手术与 2019 年的 1,545 人相比（下降 39.0%）。 因此，预计 COVID-19 将对举宫器设备市场产生重大影响。 然而，随着 COVID-19 病例的减少，预计市场将在预测期内完全復苏。
推动所研究市场增长的因素包括与女性生殖系统相关的疾病负担不断增加、技术进步不断增加以及对微创外科手术的需求不断增加。 与女性生殖系统相关的常见疾病包括子宫内膜异位症、宫颈癌、子宫肌瘤、间质细胞病和多囊卵巢综合征。 根据世界卫生组织 (WHO) 2022 年 2 月更新，宫颈癌是全球女性第四大常见癌症，2020 年新增病例 604,000 例，死亡 34 例，估计为 2,000 例。 到 2020 年，全球约 90% 的新增病例和死亡病例将发生在低收入和中等收入国家。
根据 endometriosis.org 于 2021 年 3 月发表的一篇文章，据估计，子宫内膜异位症在生育期会影响十分之一的女性，通常年龄在 15 至 49 岁之间。全球约有 1.76 亿女性。 因此，子宫内膜异位症的高患病率将增加对子宫切除手术的需求，从而增加对子宫机械手设备的需求并推动市场增长。
此外，确定子宫操纵器功效的研发程序将增加其采用率，从而促进市场的显着增长。 例如，在 2020 年 12 月发表的“子宫操纵器在全腹腔镜子宫切除术中的安全性和实用性”研究中，宫内操纵器可以在大子宫、严重子宫内膜异位症、直肠阴道粘连和局部麻醉的情况下提供支持。 因此，这些设备覆盖范围的扩大将提高它们的采用率并推动市场。 然而，在研究期间，对其中一些设备和产品批准的严格监管预计会限制市场增长。
举宫器的市场趋势
腹腔镜子宫切除术部分预计在预测期内占据最大的市场份额
全腹腔镜子宫切除术 (TLH) 是一种通过四个小（1/2' 至 1'）腹部切口切除子宫和子宫颈的手术。 该手术还可能包括切除卵巢和输卵管，具体取决于患者。 TLH 用于治疗子宫疾病，例如子宫肌瘤、卵巢和阴道的盆腔疼痛感染以及异常阴道出血。
这些疾病负担的增加和研发研究的增长等因素预计将推动市场的增长。 例如，根据 2021 年 8 月发表的一项题为“从工作台到床边评估未满足的需求的肌瘤”的研究结果，平滑肌肿瘤，有时也称为子宫肌瘤，起源于子宫肌层，大约 30% 至 35% 的女性使用超声波检测确定患有肌瘤，预计美国 70% 以上的女性将在 50 岁时患上肌瘤。 此外，根据相同的数据，在美国，25% 患有子宫肌瘤的女性症状严重到需要就医。 因此，女性子宫肌瘤的高患病率有望推动市场发展，并增加宫腔镜检查程序和这些程序中使用的子宫操纵器。
此外，越来越多的研究表明在 TLH 手术期间使用举宫器的有效性和安全性将提高其适用性，这也将有助于市场增长。 例如，根据研究“使用新设计的子宫操纵器（Halder's）进行全腹腔镜子宫切除术”，“使用新设计的子宫操纵器（Halder's）进行全腹腔镜子宫切除术：安全性、有效性、预防穿孔”，2020 年 4 月使用 Halders 子宫操纵器，它是执行 TLH 的简单、智能和简单的选择，并发症更少，手术效果更佳。 这种操纵器可供没有经验的人在阴道内使用，这将对市场的增长产生积极影响。 2021 年 4 月发表的“腹腔镜单点子宫切除术。文献综述和程序描述”研究表明，宫内操纵器可以更好地暴露骨盆区域，暴露手术野的正确手术平面，建议通过以下方式帮助外科医生 因此，在 TLH 手术期间宫内操纵器的额外好处将推动市场增长。 因此，由于上述因素，该研究涵盖的市场预计在研究期间将显着增长。
预计在预测期内北美将占据很大的市场份额
北美举宫器市场增长的主要驱动力是宫颈癌和子宫内膜异位症等女性生殖系统疾病负担的加重、微创手术需求的增加以及技术进步的不断提高。
北美地区的美国对所研究市场的显着增长做出了贡献。 这些疾病在该国日益增加的负担将提振市场。 例如，根据美国癌症协会 2022 年 1 月的更新，该国将在 2022 年诊断出约 14,100 例浸润性宫颈癌新病例，估计有 4,280 名妇女死于该病。 因此，与宫颈癌相关的高患病率和高死亡率将促进其早期治疗，从而增加对子宫机械手装置的需求，因为它们用于对抗宫颈癌，从而推动市场，你将不得不推高。
此外，市场上研发研究的兴起也将推动市场的增长。 例如，接受微创手术治疗早期子宫癌的患者体内放置了举宫器，而手术过程中获得的液体中没有放置举宫器的患者体内有癌细胞。一项前瞻性、多中心、随机、评估的非劣效性 3 期试验将于 2021 年 5 月开始。 此类研究可以帮助评估子宫操纵器的有效性和安全性，并可以提高其适用性，从而促进市场增长。
在国家癌症中心2021年5月发表的论文《For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining》中，在微创手术中使用举宫器，术者对子宫及周围结构进行了提示提高访问和可视化能力 因此，由于子宫操纵器在微创手术期间协助外科医生，预计在研究期间对其的需求将增长，从而推动市场增长。 因此，由于上述因素，预计所研究的市场将在预测期内增长。
子宫操纵器设备市场竞争对手分析
由于存在多个市场参与者，子宫操纵器设备市场竞争适中。 市场上的主要参与者包括 Conkin Surgical Instrument Ltd.、CooperSurgical Inc.、B. Braun Melsungen AG、KARL STORZ GmbH & Co.KG、CONMED Corporation。
其他好处
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第1章介绍
- 研究假设和市场定义
- 调查范围
第2章研究方法论
第 3 章执行摘要
第4章市场动态
- 市场概览
- 市场驱动因素
- 与女性生殖系统相关的疾病负担不断增加
- 技术进步和手术程序增多
- 市场製约因素
- 严格的产品审批规定
- 手术费用高
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（基于价值的市场规模 - 百万美元）
- 通过申请
- 腹腔镜全子宫切除术 (TLH)
- 腹腔镜宫颈内膜切除术 (LSH)
- 腹腔镜阴道子宫切除术 (LAVH)
- 腹腔镜宫颈切除术
- 其他应用
- 按产品类型
- Dones 型子宫体操纵器
- Tintara 型子宫体手术器械
- Clermont-Ferrand 子宫切开术装置
- 霍尔型子宫体调节器
- Advancula arch 型子宫辅助装置
- 最终用户
- 医院
- 妇科诊所
- 门诊手术中心
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 南非
- 其他中东地区
- 南美洲地区
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第6章竞争格局
- 公司简介
- Conkin Surgical Instrument Ltd.
- CooperSurgical Inc.
- B. Braun Melsungen AG
- KARL STORZ GmbH & Co. KG
- CONMED Corporation
- RUDOLF Medical GmbH+Co. KG
- Richard Wolf GmbH
- Utah Medical Products, Inc.
- Purple Surgical
- Clinical Innovations, LLC
- Bissinger Medizintechnik
- LSI Solutions, Inc.
第7章 市场机会与今后动向
The uterine manipulator devices market is expected to witness a CAGR of 5.8% during the study period, 2022-2027.
The COVID-19 pandemic was a challenge for healthcare providers across the world as due to the high infectivity of SARS-CoV-2, the resources were diverted for the care of COVID-19 patients which affected the healthcare services other than COVID-19 which also affected the uterine manipulator devices market. For instance, according to the research study published in October 2021, titled "Analysis of COVID-19 Response and Impact on Gynecologic Surgery at a Large Academic Hospital System", during the height of the pandemic, many patients had considerable delays in accessing gynecologic surgical care, and 942 gynecologic cases were performed in 2020 versus 1,545 cases in 2019 (a 39.0% drop). Hence, COVID-19 is expected to have a significant impact on the uterine manipulator devices market. However, with the declining cases of COVID-19, the market is expected to regain its full potential over the forecast period.
The factors propelling the studied market growth are the growing burden of diseases related to the female reproductive system, increasing technological advancements, and rising demand for minimally invasive surgical procedures. Common diseases related to the female reproductive system are endometriosis, cervical cancer, uterine fibroids, interstitial cytosis, and polycystic ovary syndrome, among others. According to February 2022 update by World Health Organization, cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries.
According to an article published by endometriosis.org in March 2021, endometriosis affects an estimated 1 in 10 women during their reproductive years, usually between the ages of 15 to 49, which is approximately 176 million women in the world. Thus, the high prevalence of endometriosis will increase the demand for hysterectomy procedures, thereby driving the demand for uterine manipulation devices, thus propelling the market growth.
Additionally, the research and development procedures establishing the efficacies of the intrauterine manipulator will increase its adoption, thereby contributing to the significant growth of the market. For instance, the study "Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness," published in December 2020, suggested that uterine manipulator provides support in cases of large uteri, severe endometriosis, recto vaginal adhesions, and regional anesthesia. Thus, the expanded scope of these devices will increase their adoptability, thus driving the market. However, some of these devices and stringent regulations regarding product approvals are expected to restrain the market growth during the study period.
Uterine Manipulation Devices Market Trends
Total Laparoscopic Hysterectomy Segment is Expected to Account for the Largest Market Share During the Forecast Period
Total Laparoscopic Hysterectomy (TLH) is the removal of the uterus and cervix through four small (1/2'- 1') abdominal incisions. This procedure may also include the removal of the ovaries and tubes, depending on the patient. TLH is performed to treat diseases of the uterus, such as fibroids, pelvic pain infection in ovaries and vaginal tubes, abnormal vaginal bleeding, and others.
The factors such as the growing burden of these diseases and growing research and development studies are expected to boost the market growth. For instance, according to the research study published in August 2021, titled "Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside", smooth muscle tumors called leiomyomas, sometimes known as uterine fibroids, develop from the myometrium and using ultrasound detection, around 30%-35% of women will be identified as having fibroids, but it is predicted that more than 70% of women will do so by age 50 in the United States. Also, as per the same source, in the US, 25% of women with uterine fibroids will have symptoms bad enough to need medical attention. Hence, the high prevalence of fibroids among women is expected to increase the hysteroscopy procedures and uterine manipulators, as that is used in these procedures, thus driving the market.
Additionally, rising research studies proving the efficacy and safety of using uterine manipulators during TLH procedures will increase its adaptability, which will also contribute to market growth. For instance, according to the study "Total Laparoscopic Hysterectomy with a Newly Designed Uterine Manipulator (Halder's): Safety, Efficacy and Perforation Prevention" published in April 2020, the Halder's uterine manipulator is an easy, smart and simple option to do TLH, which reduces the complications and have more favorable operative outcomes. This manipulator can be used by inexperienced persons at the vaginal end, thus, positively impacting the market growth. The study "Laparoendoscopic Single Site Hysterectomy: Literature Review and Procedure Description," published in April 2021, suggests that intra-uterine manipulator permits a better exposure of the pelvic field, helping the surgeon by exposing the correct surgical planes of the operative field. Thus, added advantages of uterine manipulators during TLH procedures will fuel the market growth. Thus, owing to the above-mentioned factors, the studied market is expected to grow significantly during the study period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
The primary driving factors for the growth of the North American uterine manipulator market are the rising burden of female reproductive system diseases such as cervical cancer, endometriosis, and others, rising demand for minimally invasive surgeries, and rising technological advancements.
The United States within North America contributes to significant growth in the studied market. The rising burden of these diseases in the country will boost the market. For instance, according to a January 2022 update by the American Cancer Society, approximately 14,100 new cases of invasive cervical cancer will be diagnosed in 2022 in the country, with estimated 4,280 women deaths from the disease. Thus, the high prevalence and mortality rate associated with cervical cancer will boost its early treatment, thereby driving the demand for uterine manipulator devices as they are used for addressing cervical cancer, thus boosting the market.
The rising research and development studies in the market will also boost the market growth. For instance, a prospective, multicenter, randomized non-inferiority phase III study was initiated in May 2021 to evaluate if patients undergoing a minimally invasive surgery for early-stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed. Such studies will help in evaluating the efficacy and safety of uterine manipulators, which can boost their adaptability; therefore, such studies might contribute to market growth.
The article "For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining," published by National Cancer Institute in May 2021, suggested that uterine manipulators are used during minimally invasive procedures to improve the surgeon's ability to access and visualize the uterus and surrounding structures. Thus, as uterine manipulators assist surgeons during minimally invasive surgeries, the demand for the same is expected to grow during the study period, which will propel the market growth. Hence, owing to the above-mentioned factors, the studied market is expected to grow during the forecast period.
Uterine Manipulation Devices Market Competitor Analysis
The uterine manipulation devices market is moderately competitive owing to the presence of several market players. Some of the key players in the market are Conkin Surgical Instrument Ltd., CooperSurgical Inc., B. Braun Melsungen AG, KARL STORZ GmbH & Co. KG, CONMED Corporation, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Diseases Related to Female Reproductive System
- 4.2.2 Technological Advancements and Rise in Surgical Procedures
- 4.3 Market Restraints
- 4.3.1 Stringent Regualtions Regarding Product Approvals
- 4.3.2 High Cost of Procedures
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
- 5.1 By Application
- 5.1.1 Total Laparoscopy Hysterectomy (TLH)
- 5.1.2 Laparoscopic Supracervical Hysterectomy (LSH)
- 5.1.3 Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
- 5.1.4 Sacrocolpopexy
- 5.1.5 Other Applications
- 5.2 By Product Type
- 5.2.1 Donnez Type Uterine Manipulators
- 5.2.2 Tintara Type Uterine Manipulators
- 5.2.3 Clermont -Ferrand Type Uterine Manipulators
- 5.2.4 Hohl Type Uterine Manipulators
- 5.2.5 Advincula Arch Type Uterine Manipulators
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Specialized Gynecology Clinics
- 5.3.3 Ambulatory Surgical Centers
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Conkin Surgical Instrument Ltd.
- 6.1.2 CooperSurgical Inc.
- 6.1.3 B. Braun Melsungen AG
- 6.1.4 KARL STORZ GmbH & Co. KG
- 6.1.5 CONMED Corporation
- 6.1.6 RUDOLF Medical GmbH + Co. KG
- 6.1.7 Richard Wolf GmbH
- 6.1.8 Utah Medical Products, Inc.
- 6.1.9 Purple Surgical
- 6.1.10 Clinical Innovations, LLC
- 6.1.11 Bissinger Medizintechnik
- 6.1.12 LSI Solutions, Inc.
